Gary Watts

Director, Formulation Development & Analytics

Gary is the Director of Formulation Development at Abzena and leads our pre-formulation and formulation development services.

Gary is an expert in formulation and has a wealth of experience partnering with clients to establish optimal formulations for the required administration route, including very high-concentration products. He has worked with peptides, antibodies, vaccines, antibody-drug conjugates (ADCs), and novel antibody formats such as fusion proteins and multi-specific antibodies. He is also a co-inventor on two formulation patents.

Gary has over 10 years’ experience in formulation and analysis of Biologics. Before joining Abzena, Gary worked at Arecor Ltd., leading formulation studies covering early-stage and late-stage development. He set up the R&D department and supported many programs treating diabetes, Duchenne muscular dystrophy, scleroderma, influenza, and various autoimmune diseases.

Contact Our Expert

What is your biologics formulation development challenge? Ask Gary today.